NOVO NORDISK supplier risk profile Q1 2026: 55 shipments, 12 suppliers, Denmark-focused pharmaceutical sourcing.
NOVO NORDISK imported 55 shipments across 12 suppliers in Q1 2026, sourcing from 7 countries with a concentration in Denmark at 51% of total shipments. The company's top supplier, also NOVO NORDISK (Denmark), accounted for 22 shipments spanning chemical intermediates and active pharmaceutical ingredients across HS Chapter 29 (organic chemicals). Other material suppliers include WAFIOS (Germany, 7 shipments) and THERMO FISHER SCIENTIFIC NZ (6 shipments), reflecting a diversified but Denmark-heavy procurement strategy.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
One name matching a sanctions watchlist was identified in the import data. No suppliers registered exposure under forced-labor proximity frameworks, indicating low detected UFLPA supply-chain risk as of Q1 2026.
12 distinct tier-1 suppliers in Q1 2026
| NOVO NORDISK | Denmark | 22 |
| WAFIOS | Germany | 7 |
| THERMO FISHER SCIENTIFIC NZ | New Zealand | 6 |
| MARIAGER SALT SPECIALTIES | Denmark | 4 |
| VYNOVA BELGIUM | Belgium | 4 |
| POUL JOHANSEN MASKINER | Denmark | 2 |
| BIO SPRINGER | Germany | 2 |
| PHARMATEC | Germany | 2 |
Share of Q1 2026 inbound shipments by source country
38 tier-2 + 169 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.